Cargando…

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1

Mostrar otras versiones (1)

The aim of this work was to start collecting information on rational combination of antibody (Ab) and T cell vaccines into single regimens. Two promising candidate HIV-1 vaccine strategies, sequential isolates of CH505 virus Envs developed for initiation of broadly neutralizing antibody lineages and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wee, Edmund G., Moyo, Nathifa A., Saunders, Kevin O., LaBranche, Celia, Donati, Filippo, Capucci, Silvia, Parks, Robert, Borthwick, Nicola, Hannoun, Zara, Montefiori, David C., Haynes, Barton F., Hanke, Tomáš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657236/ https://www.ncbi.nlm.nih.gov/pubmed/31367651 http://dx.doi.org/10.1016/j.omtm.2019.06.003

Ejemplares similares

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
por: Wee, Edmund G., et al.
Publicado: (2022)

Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice()
por: Ondondo, Beatrice, et al.
Publicado: (2013)

Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
por: Wee, Edmund G., et al.
Publicado: (2021)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2017)

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2023)

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
por: Borthwick, Nicola J, et al.
Publicado: (2015)

Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
por: Blasi, Maria, et al.
Publicado: (2020)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
por: Moyo, Nathifa, et al.
Publicado: (2017)

Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells
por: Ternette, Nicola, et al.
Publicado: (2015)

Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
por: Kilpeläinen, Athina, et al.
Publicado: (2019)

Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA
por: Matthews, David A., et al.
Publicado: (2023)

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
por: Moyo, Nathifa, et al.
Publicado: (2018)

Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine
por: Rahim, Md Niaz, et al.
Publicado: (2019)

Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
por: Mohamed, Yehia S., et al.
Publicado: (2020)

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
por: Klasse, P. J., et al.
Publicado: (2018)

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
por: Hancock, Gemma, et al.
Publicado: (2017)

505 Verdades publicitarias /
por: Pratt Gaballí, Pedro
Publicado: (2001)

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
por: Mothe, Beatriz, et al.
Publicado: (2020)

SUN-505 The Invincible Parathyroid Gland
por: Mayorga, Mabel, et al.
Publicado: (2019)

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
por: Borthwick, Nicola J., et al.
Publicado: (2018)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Identification of novel HIV-1-derived HLA-E-binding peptides
por: Hannoun, Zara, et al.
Publicado: (2018)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

I4 Hotspot: runs 505 and 508
por: Risselada, Thys
Publicado: (1974)

SUN-505 Total Thyroidectomy in Severe Hyperthyroidism
por: Del Alamo, Cynthia Diana Zegarra, et al.
Publicado: (2020)

505 Assessing the Accessibility of CTSA Training Resources
por: Ebanks, Yasheca T, et al.
Publicado: (2022)

A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways
por: Klein, Kevin, et al.
Publicado: (2021)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
por: Alexander, J, et al.
Publicado: (2012)

Equine Arteritis Virus in Monocytic Cells Suppresses Differentiation and Function of Dendritic Cells
por: Moyo, Nathifa A., et al.
Publicado: (2023)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques
por: Pahar, Bapi, et al.
Publicado: (2016)

Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia
por: Morrell, Ruth, et al.
Publicado: (2013)

POS-505 THYROID DISEASE IN TIME OF COVID19
por: Ajimi, K., et al.
Publicado: (2022)

SAT505 Pericardial Effusion as The Primary Manifestation of Hypothyroidism
por: Lai, William, et al.
Publicado: (2023)

Ontogeny and phylogeny /
por: Gould, Stephen Jay
Publicado: (1977)

Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_la2gjrlnmc41mg04cvpmklplfj